Navigation Links
Cardica Completes Enrollment In European Clinical Trial For Surgical Cutting And Stapling Device
Date:5/15/2013

REDWOOD CITY, Calif., May 15, 2013 /PRNewswire/ -- Cardica, Inc. (Nasdaq: CRDC) today announced it has completed enrollment in the European clinical study for its MicroCutter XCHANGE™ 30, a cartridge-based cutting/stapling device with a 5-millimeter shaft diameter and cross-sectional area more than six times smaller than standard 12-millimeter surgical staplers used today. The trial is designed to evaluate the safety of the XCHANGE 30 in a variety of gastrointestinal surgical procedures to support a 510(k) filing for market clearance from the U.S. Food and Drug Administration (FDA).

"Based on consistent product performance and positive unaudited clinical outcomes of the trial to date, following standard statistical analyses we expect to file regulatory documents with the FDA in the third quarter of calendar 2013," said Bernard A. Hausen , M.D., Ph.D., president and chief executive officer of Cardica. "We would like to express our sincere thanks to the investigators and patients for their enthusiasm in participating in the trial to advance the XCHANGE 30, the smallest cutting and stapling device available today."

The prospective, single-arm, multi-center, non-inferiority clinical study enrolled 160 patients at seven centers in Germany. The results of the procedures will be compared to historical adverse event reports for similar procedures performed with currently available stapling devices. Typical adverse events associated with current surgical staplers include staple line leakage, staple line bleeding, staple line strictures and surgical infections.

About Cardica 
Cardica designs and manufactures proprietary stapling and anastomotic devices for cardiac and laparoscopic surgical procedures. Cardica's technology portfolio is intended to minimize
'/>"/>

SOURCE Cardica, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cardica Announces Fiscal 2013 Third Quarter Financial Results
2. Cardica to Announce Fiscal 2013 Third Quarter Financial Results On Tuesday, April 30, 2013
3. Cardica Prices Public Offering Of Common Stock
4. Cardica Announces Proposed Public Offering of Common Stock
5. Cardica Updates Enrollment Progress In European Clinical Trial
6. Cardica Announces Fiscal 2013 Second Quarter Financial Results
7. Cardica To Announce Fiscal 2013 Second Quarter Financial Results On Thursday, January 31, 2013
8. Cardica To Present At Lazard Capital Markets 9th Annual Healthcare Conference
9. Cardica Announces Fiscal 2013 First Quarter Financial Results
10. Cardica To Present At 2012 Wedbush PacGrow Life Sciences Management Access Conference
11. Cardica Announces Fiscal 2012 Fourth Quarter And Year End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... UNION CITY, Calif. , Nov. 21, 2014 /PRNewswire/ ... products company manufacturing point-of-care instruments and consumables for the ... lab services to the veterinary and research markets in ... the completion of a stock purchase agreement to acquire ... United Kingdom based distribution organization. The ...
(Date:11/21/2014)... 21, 2014 Clementia Pharmaceuticals, ... Agency (EMA) has granted Orphan Medicinal Product ... candidate, for the treatment of fibrodysplasia ossificans ... disabling genetic disease characterized by painful, recurrent ... new abnormal bone formation. This process, known ...
(Date:11/21/2014)... YORK , Nov. 20, 2014  Market research firm ... the "Year of The Buy, in the medical device ... for medical devices will produce just 3% growth this ... actions, including acquisitions of product lines and entrance by ... annual survey of medical devices, The Global Market ...
Breaking Medicine Technology:Abaxis Acquires UK-based Distribution Organization 2Abaxis Acquires UK-based Distribution Organization 3Abaxis Acquires UK-based Distribution Organization 4Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2
... NEW YORK, Sept. 12, 2011 A revolutionary new ... other technology - - the VivoSight® Optical Coherence ... to dermatologists in the U.S. for the first time. ... skin surface instantly, providing additional information which will allow ...
... Sept. 12, 2011 Intarcia Therapeutics, Inc. announced ... ITCA 650 (DUROS® subcutaneous continuous delivery of exenatide) ... the 47th Annual Meeting of the European Association ...  All three presentations are scheduled for Wednesday, September ...
Cached Medicine Technology:Revolutionary Device for Use in Detecting Non-Melanoma Skin Cancer in Real Time, Alleviates Patient Stress, Can Reduce Invasive Biopsy 2Revolutionary Device for Use in Detecting Non-Melanoma Skin Cancer in Real Time, Alleviates Patient Stress, Can Reduce Invasive Biopsy 3Revolutionary Device for Use in Detecting Non-Melanoma Skin Cancer in Real Time, Alleviates Patient Stress, Can Reduce Invasive Biopsy 4Intarcia Announces Presentations of Three Clinical Abstracts at the 47th Annual Meeting of the European Association for the Study of Diabetes 2Intarcia Announces Presentations of Three Clinical Abstracts at the 47th Annual Meeting of the European Association for the Study of Diabetes 3Intarcia Announces Presentations of Three Clinical Abstracts at the 47th Annual Meeting of the European Association for the Study of Diabetes 4
(Date:11/22/2014)... Today, Dylan Queen, a renowned brand in ... dresses; the business offers a wide range of special ... worldwide, allowing them to create multiple looks easily. , ... new collection of chic wedding dresses has been prepared ... at discounted rates now. Dylan Queen can always create ...
(Date:11/22/2014)... 2014 Discount-Dress.com is an important ... firm is to increase the company’s online market share by ... selection of bridesmaid dresses and announced a bridesmaid dress promotion ... until Dec. 30, 2014. All the dresses from this company ... , In fact, Discount-Dress.com is very good at manufacturing wedding ...
(Date:11/22/2014)... "My friend went in for a mammogram and ... an inventor from Cambria Heights, N.Y. "To add insult ... time because the first results were inaccurate. Her misfortune ... MAMO EASY to offer a more comfortable way to ... from the pain normally involved with this procedure. The ...
(Date:11/22/2014)... Nov. 22, 2014 (HealthDay News) -- The wide variety ... pose a threat for people with food allergies, an ... are so many types of food allergies that it ... the holidays," Dr. Guha Krishnaswamy, director of allergy and ... in a hospital news release. "If you know ...
(Date:11/22/2014)... This month has been a historical time for Angeldress.co.uk, ... positive reviews from some renowned review websites. Recently, the company ... a new selection of wonderful sexy wedding dresses to its ... shipping and up to an 80% discount on any order ... the most suitable dress at Angeldress.co.uk, which has garnered a ...
Breaking Medicine News(10 mins):Health News:Dylan Queen Introduces Its New Wedding Dresses 2Health News:Bridesmaid Dresses Introduced by Famous Company Discount-Dress.com For The New Year 2015 2Health News:'Tis the Season of Challenges for Those With Food Allergies 2Health News:Sexy Wedding Dresses with Special Discounts Launched by Angeldress.co.uk 2
... organ donation - where people have to opt out of donating ... tackle a growing waiting list for transplant. , That is the ... the illegal trade of body parts, who has recently joined the ... more than 7,500 patients in the UK currently on the waiting ...
... Analysis on Financial Impact of McCain, Obama,Proposals, WASHINGTON, ... on health care, and costs are continuing to skyrocket ... facing policymakers in,the United States., A detailed analysis ... for the federal government is included in the Guide ...
... on November 4th, WASHINGTON, Oct. 31 American ... should be ending rather than simply,treating breast cancer, according ... Cancer Coalition (NBCC). Women see two main obstacles,hindering that ... committed as,they should be to saving lives as opposed ...
... one of the nation’s first and largest providers of kidney dialysis ... its chief researchers will present at the American Society of Nephrology’s ... 4-9, 2008 at the Pennsylvania Convention Center in Philadelphia. ... ...
... Light, yet Stylish and Sophisticated, Life is Full ... to Moderate,Hearing Loss., PISCATAWAY, N.J., Oct. 31 ... hallmark of Siemens Hearing,Instruments, Inc., a leading manufacturer ... commitment by announcing their new Life,hearing instruments at ...
... of bacterial infection , , FRIDAY, Oct. 31 (HealthDay News) ... unless it has been prescribed by an eye doctor. ... Association (AOA), which is concerned about people wearing decorative ... the U.S. Food and Drug Administration regulates decorative lenses ...
Cached Medicine News:Health News:'Opt out' system could solve donor organ shortage, says researcher 2Health News:Candidates' Proposals to Address Health Care Cost, Coverage and Quality Come at Major Costs 2Health News:Candidates' Proposals to Address Health Care Cost, Coverage and Quality Come at Major Costs 3Health News:National Breast Cancer Coalition Survey Reveals That Lack of Commitment and Funding Impede the Fight Against Breast Cancer 2Health News:National Breast Cancer Coalition Survey Reveals That Lack of Commitment and Funding Impede the Fight Against Breast Cancer 3Health News:National Breast Cancer Coalition Survey Reveals That Lack of Commitment and Funding Impede the Fight Against Breast Cancer 4Health News:National Breast Cancer Coalition Survey Reveals That Lack of Commitment and Funding Impede the Fight Against Breast Cancer 5Health News: Satellite Healthcare Will Present at the American Society of Nephrology's Renal Week – Booth 527 : November 4-9, 2008 2Health News: Satellite Healthcare Will Present at the American Society of Nephrology's Renal Week – Booth 527 : November 4-9, 2008 3Health News:Siemens Introduces Life, an Open Fit Hearing Instrument That is Beautiful, Smart, and Discreet 2Health News:Siemens Introduces Life, an Open Fit Hearing Instrument That is Beautiful, Smart, and Discreet 3Health News:Siemens Introduces Life, an Open Fit Hearing Instrument That is Beautiful, Smart, and Discreet 4Health News:Decorative Halloween Eye Lenses May Pose Serious Risks 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: